Merus N.V. (MRUS)
Dec 30, 2025 - MRUS was delisted (reason: acquired by GMAB)
81.00
-0.50 (-0.61%)
Inactive · Last trade price on Dec 16, 2025

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Innovative Therapeutics
43.95M
Innovative Therapeutics Growth
5.68%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Netherlands
43.95M
Netherlands Growth
5.68%